Table 2
Time to absolute neutrophil count (ANC) recovery, duration of antibiotic use, mechanical ventilation, and intensive care, and mortality
| rhG-CSF (n=13) | Placebo (n=15) | p Value | |
| Time to ANC recovery to >5 × 109/l (days) | 2 (1–3) | 5 (4–7) | <0.001 |
| Duration of antibiotics (days) | 8 (6–16) | 16 (13–35) | 0.14 |
| Duration of mechanical ventilation (days) | 5 (3–13) | 12 (6–34) | 0.23 |
| Duration of intensive care (days) | 8 (3–17) | 12 (8–34) | |
| Deaths during 42 day study period | 1 | 4 | 0.33 |
| Total deaths at 6 and 12 months postmenstrual age | 1 | 7 | 0.038 |
-
Where applicable, results are presented as median (interquartile range).
-
rhG-CSF, recombinant human granulocyte colony stimulating factor.
